Evidence map›Paper›PMID 26813944›Full record

ArticleEuropean journal of human genetics : EJHG2016

Copy number variation of scavenger-receptor cysteine-rich domains within DMBT1 and Crohn's disease.

Shamik Polley, Natalie Prescott, Elaine Nimmo, Colin Veal, Ida Vind, Pia Munkholm, Peder Fode, John Mansfield, Paal Skyt Andersen, Jack Satsangi and 2 more

Open access · hybridAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 3 countries.

Shamik PolleyDepartment of Genetics, University of Leicester, Leicester, UK.
Natalie PrescottDepartment of Medical and Molecular Genetics, King's College London, London, UK.
Elaine NimmoCentre for Genomic and Experimental Medicine, University of Edinburgh, Edinburgh, UK.
Colin VealDepartment of Genetics, University of Leicester, Leicester, UK.
Ida VindMicrobiology and Infection Control Unit, Statens Serum Institut, Copenhagen, Denmark.
Pia MunkholmMicrobiology and Infection Control Unit, Statens Serum Institut, Copenhagen, Denmark.
Peder FodeMicrobiology and Infection Control Unit, Statens Serum Institut, Copenhagen, Denmark.
John MansfieldInstitute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK.
Paal Skyt AndersenMicrobiology and Infection Control Unit, Statens Serum Institut, Copenhagen, Denmark.
Jack SatsangiCentre for Genomic and Experimental Medicine, University of Edinburgh, Edinburgh, UK.
Christopher G MathewDepartment of Medical and Molecular Genetics, King's College London, London, UK.
Edward J HolloxDepartment of Genetics, University of Leicester, Leicester, UK.
Statens Serum Institut · DKUniversity of Leicester · GBUniversity of Edinburgh · GBKing's College London · GBNewcastle University · GBUniversity of the Witwatersrand · ZA

Funding

Chief Scientist Office CZB/4/540Chief Scientist Office ETM/137Chief Scientist Office ETM/75Medical Research Council G0600329Medical Research Council G0800675Medical Research Council G0800759Medical Research Council G0801123Medical Research Council G1001799Medical Research Council MR/N01104X/1Wellcome TrustWellcome Trust 076113Wellcome Trust 085475Wellcome Trust 090355
6 · The paper itself

Abstract

Previous work has shown that the gene DMBT1, which encodes a large secreted epithelial glycoprotein known as salivary agglutinin, gp340, hensin or muclin, is an innate immune defence protein that binds bacteria. A deletion variant of DMBT1 has been previously associated with Crohn's disease, and a DMBT1(-/-) knockout mouse has increased levels of colitis induced by dextran sulphate. DMBT1 has a complex copy number variable structure, with two, independent, rapidly mutating copy number variable regions, called CNV1 and CNV2. Because the copy number variable regions are predicted to affect the number of bacteria-binding domains, different alleles may alter host-microbe interactions in the gut. Our aim was to investigate the role of this complex variation in susceptibility to Crohn's disease by assessing the previously reported association. We analysed the association of both copy number variable regions with presence of Crohn's disease, and its severity, on three case-control cohorts. We also reanalysed array comparative genomic hybridisation data (aCGH) from a large case-control cohort study for both copy number variable regions. We found no association with a linear increase in copy number, nor when the CNV1 is regarded as presence or absence of a deletion allele. Taken together, we show that the DMBT1 CNV does not affect susceptibility to Crohn's disease, at least in Northern Europeans.

Indexed as

DNA Copy Number VariationsAllelesCalcium-Binding ProteinsCase-Control StudiesCrohn DiseaseCysteineDNA-Binding ProteinsHumansProtein DomainsReceptors, Cell SurfaceTumor Suppressor ProteinsCalcium-Binding ProteinsCysteineDMBT1 protein, humanDNA-Binding ProteinsReceptors, Cell SurfaceTumor Suppressor Proteins

Identifiers

PMID26813944
PMCPMC4851238
OpenAlexW2262492105

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.